| In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG®) G Garrido, D González, Y Lemus, D Garcıa, L Lodeiro, G Quintero, ... Pharmacological research 50 (2), 143-149, 2004 | 327 | 2004 |
| Gallic acid indanone and mangiferin xanthone are strong determinants of immunosuppressive anti-tumour effects of Mangifera indica L. bark in MDA-MB231 breast cancer cells D García-Rivera, R Delgado, N Bougarne, G Haegeman, WV Berghe Cancer Letters 305 (1), 21-31, 2011 | 186 | 2011 |
| Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin D Garcıa, R Delgado, FM Ubeira, J Leiro International Immunopharmacology 2 (6), 797-806, 2002 | 171 | 2002 |
| Anti‐allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin DG Rivera, IH Balmaseda, AÁ León, BC Hernández, LM Montiel, ... Journal of Pharmacy and Pharmacology 58 (3), 385-392, 2006 | 143 | 2006 |
| Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of … G Garrido, R Delgado, Y Lemus, J Rodrıguez, D Garcıa, AJ Núñez-Sellés Pharmacological Research 50 (2), 165-172, 2004 | 136 | 2004 |
| Mangifera indica L. extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma DG Rivera, I Hernández, N Merino, Y Luque, A Álvarez, Y Martín, ... Journal of Pharmacy and Pharmacology 63 (10), 1336-1345, 2011 | 96 | 2011 |
| The paradox of natural products as pharmaceuticals: Experimental evidences of a mango stem bark extract AJ Núñez-Sellés, R Delgado-Hernández, G Garrido-Garrido, ... Pharmacological Research 55 (5), 351-358, 2007 | 86 | 2007 |
| SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies Y Valdes-Balbin, D Santana-Mederos, L Quintero, S Fernández, ... ACS Chemical Biology 16 (7), 1223-1233, 2021 | 83 | 2021 |
| Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind … ME Toledo-Romaní, M García-Carmenate, C Valenzuela-Silva, ... The Lancet Regional Health–Americas 18, 2023 | 73* | 2023 |
| An Anacardiaceae preparation reduces the expression of inflammation-related genes in murine macrophages J Leiro, D Garcıa, JA Arranz, R Delgado, ML Sanmartın, F Orallo International Immunopharmacology 4 (8), 991-1003, 2004 | 69 | 2004 |
| Resveratrol modulates rat macrophage functions J Leiro, E Alvarez, D Garcıa, F Orallo International immunopharmacology 2 (6), 767-774, 2002 | 67 | 2002 |
| Safety and preliminary immunogenicity of Cuban pneumococcal conjugate vaccine candidate in healthy children: A randomized phase I clinical trial CP Dotres, R Puga, Y Ricardo, CR Broño, B Paredes, V Echemendía, ... Vaccine 32 (41), 5266-5270, 2014 | 64 | 2014 |
| Novel ACE2-independent carbohydrate-binding of SARS-CoV-2 spike protein to host lectins and lung microbiota F Chiodo, SCM Bruijns, E Rodriguez, RJE Li, A Molinaro, A Silipo, ... BioRxiv, 2020.05. 13.092478, 2020 | 58* | 2020 |
| A single dose of SARS-CoV-2 FINLAY-FR-1A dimeric-RBD recombinant vaccine enhances neutralization response in COVID-19 convalescents, with excellent safety profile. A … A Chang-Monteagudo, R Ochoa-Azze, Y Climent-Ruiz, ... medRxiv, 2021.02. 22.21252091, 2021 | 56* | 2021 |
| Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates Y Méndez, J Chang, AR Humpierre, A Zanuy, R Garrido, AV Vasco, ... Chemical science 9 (9), 2581-2588, 2018 | 52 | 2018 |
| Molecular aspects concerning the use of the SARS-CoV-2 receptor binding domain as a target for preventive vaccines Y Valdes-Balbin, D Santana-Mederos, F Paquet, S Fernandez, Y Climent, ... ACS central science 7 (5), 757-767, 2021 | 50 | 2021 |
| Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials M Eugenia-Toledo-Romaní, L Verdecia-Sánchez, M Rodríguez-González, ... Vaccine 40 (31), 4220-4230, 2022 | 46* | 2022 |
| Defeating meningitis by 2030: a global road map World Health Organization World Health Organization, 2021 | 44 | 2021 |
| Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection M González-Miro, L Rodríguez-Noda, M Fariñas-Medina, D García-Rivera, ... Heliyon 3 (4), 2017 | 40 | 2017 |
| Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection M González-Miró, LM Rodríguez-Noda, M Fariñas-Medina, ... Scientific reports 8 (1), 1888, 2018 | 38 | 2018 |
Vicente Verez BencomoGeneral Director Finlay Vaccine InstituteVerified email at finlay.edu.cu
